ABSTRACT
INTRODUCTION
Work on murine experimental malaria suggests that a non-lethal outcome of a malaria infection can, in part, be explained by the ability of the mice to mount an early proinflammatory response, defined by IL-12, IFN-γ or TNF-α production (1) (2) (3) . TNF and IFN-γ act synergistically to optimize nitric oxide (NO -) production, which is implicated as an important factor in parasite killing (4) . However, overproduction of IFN-γ and TNF-α predisposes to severe pathology (5) (6) (7) , suggesting that the ability to regulate the pro-inflammatory responses is also crucial to survive the infection. IL-10 is an anti-inflammatory cytokine which is able to modulate immune responses to parasites in several ways, including by inhibiting the production of IFN-γ and IL-12. The clinical importance of IL-10 as a modulator of the pro-inflammatory responses seen in human malaria is however, yet to be defined. A low IL-10/TNF-α ratio, rather than only high levels of TNF-α, is associated with malarial anaemia (8) (9) (10) (11) . This suggests that anaemia might be promoted by high pro-inflammatory responses in the absence of appropriate levels of anti-inflammatory factors. In severe malaria, lower levels of plasma IL-12 and NO -combined with higher IL-10 levels suggest that anti-parasitic responses might be suppressed by high levels of anti-inflammatory responses, resulting in severe disease (12, 13) .
The relationship between initial plasma levels of IL-10 and parasite densities, determined daily during 3 days of treatment, was studied in 104 children with acute uncomplicated Plasmodium falciparum malaria, with the hypothesis that IL-10 inhibits anti-parasitic immune responses. The Tanzanian children, aged between 1 and 4 years, were admitted to the hospital for a trial comparing four different anti-malaria treatment regimes.
METHODS

Study area and patients
Data and samples in this work were obtained from patients included in a study designed to compare antipyretic, parasitological and immunological effects of four different antimalaria treatment regimes (14) . The study was carried out in Kibaha District Hospital 40 km north-west of Dar es Salaam, Tanzania, an area holoendemic for malaria with largely perennial transmission of mainly P. falciparum. Children between 12 and 59 months of age attending the primary health care unit of the hospital, between 3 July and 20 August 1998, were included in the study if they fulfilled the inclusion criteria of uncomplicated mono-infection with P. falciparum (2000 -250 000 parasites /µL, axillary temperature 37·5 -40·0°C). Children were not eligible for the study if they had severe malaria (as defined by altered level of consciousness, convulsions, prostration, circulatory shock or respiratory distress), hyperparasitaemia (> 250 000 parasites / µL) or severe anaemia (haemoglobin level below 5·0 g/ dL). Children with signs of coexisting diseases were also excluded. The guardians of the children satisfying the inclusion criteria were asked for their informed consent for the children to be finally enrolled into the study. Ethical clearance has been obtained from the Ministry of Health, Tanzania and the Research Ethical committee of the Karolinska Institutet, Stockholm, Sweden. The patients were admitted to the hospital and treated with chloroquine phosphate alone (F Hoffman-La Roche, Basel, Switzerland) once daily for 3 days, sulfadoxine / pyrimethamine (SP) alone (F HoffmanLa Roche, Basel, Switzerland) single dose, or SP + chloroquine or SP + paracetamol.
Sample collection
All children remained in the ward for 3 days. Axillary body temperature was measured with a digital thermometer at attendance to the primary health care unit of the hospital and at the start of treatment (Time 0). Parasite species were assessed by Giemsa-stained thin blood smears at admission, and parasite densities by thick blood smears daily for 4 days. The parasite densities were estimated by counting asexual parasites per 200 leucocytes in the thick smear and expressed as number of parasites per µL of blood, assuming an average number of 8000 leucocytes per µL of blood. Blood samples for cytokine determination were collected on day 0 (before start of treatment), day 2 and day 3. The plasmas were immediately separated by centrifugation and stored at −30°C during the time of the study (at the most 2 months) and thereafter stored at −70°C until transferred on dry ice and stored at −70°C until analysed in the year 2000. Out of 169 patients who participated in the study for 72 h, 104, equally distributed between the four treatment groups, were randomly selected for cytokine analyses.
Cytokine determination
Cytokine analyses were performed by a sandwich ELISA. Half-area ELISA plates (Corning Incorporated, Corning, NY, USA) were coated overnight at 4°C with 25 µL (1 µg/mL) catcher α-IL-10 antibodies (9D7) (MABTECH, Stockholm, Sweden). Phosphate buffered saline (PBS) supplemented with 0·05% bovine serum albumin was used for blocking (90 min, at RT) and for dilution of standards and plasma samples. To ensure specific binding, blocking mouse antibodies (1DIK) (MABTECH, Stockholm, Sweden) were applied to the plates (20 µg/mL, final concentration) immediately before samples and standards and incubated overnight at 4°C. The samples from each patient were coded and distributed randomly in duplicates (diluted 1 : 1) in the plates. Bound cytokines were assayed using biotinylated α-IL-10-specific antibodies (12G8, 1 µg/mL, 25 µL/well) (MABTECH, Stockholm, Sweden) for 2 h at 37°C, followed by alkaline phosphatase (ALP)-conjugated streptavidin (MABTECH, Stockholm, Sweden) diluted 1 : 1000 and incubated (90 min, at RT). Phosphatase substrate (Sigma Diagnostics, St Louis, MO, USA) was applied and the optical density was read at 450 nm. Cytokine concentrations were calculated from standard curves obtained by incubating serial dilutions of recombinant IL-10 (NIBSC, Hertfordshire, United Kingdom). The standard was aliquoted and stored at −70°C.
The lower limit of detection, 30 pg/mL, was set according to the linear part of the standard curve and the background values of the buffer controls. The antibodies used for detection recognize both human and viral IL-10. TNF-α levels were detected with the same procedure at the same time with the antibodies Mab 1 and Mab 11 (Pharmingen, San Diego, CA, USA).
Statistical analysis
The statistical package Stata was used for data analysis. The associations of IL-10 levels (at time 0), with parasite densities at times 24, 48 and 72 h, were assessed using ordered polytomous logistic regression. With this statistical method it is possible to study the association between IL-10 levels and parasite densities even with an increasing proportion of the individuals with no parasites. Parasitaemia at time 0 was log e (x + 1) transformed, and because this measure was normally distributed, it was modelled as a continuous variable. This provided the finest grain adjustment possible in a conditional change model. By 'finest grain' we mean that adjustment for the baseline parasitaemia at zero hours uses Volume 26, Number 3, March 2004 IL-10 levels and clearance of P. falciparum the most precise measure possible and with greater precision than the subsequent measures of parasitaemia used as dependent variables. This will ensure that reported associations with parasitaemia are not artefacts of (perhaps subtle) differences at baseline parasitaemia. Models such as these are known as conditional change models because the dependent variable is conditioned on (adjusted for) an earlier measure of the same factor. Parasite densities at 48 and 72 h were not normally distributed, even after log transformation. At all time points, the measures were therefore converted into ordinal categorical variables to allow for comparable analysis for all outcome times. Parasite densities were categorized into fifths of their distribution at 24 h, with an additional category for those without any detected parasites. We used the distribution with the widest range of values (parasitaemia at 24 h) to define the boundaries for our categories. If the distribution at any of the other time points (48 or 72 h) had been used, the results would have been substantially similar but the measure would have been less sensitive. IL-10 and temperature were categorized into fifths of their distributions and age was modelled in separate years (1) (2) (3) (4) (5) . Simultaneous mutual adjustment was made for: treatment, temperature at 0 h, IL-10 at 0 h, parasite density at 0 h, age and sex. All variables were modelled as series of binary dummies with the exception of parasite density at Time 0. Interaction of IL-10 with treatment strategy was also tested. The interaction term was included in the models with adjustment for baseline parasitaemia and the other potentially confounding factors as well as the main effects (IL-10 level and treatment strategy).
RESULTS
Data distribution
Plasma levels of IL-10 were detectable in all 104 patients and categorized as shown in Table 1 . The distribution of parasite densities at 24 h was categorized by division into fifths. The same cut-points for parasitaemia were used when categorizing the distribution at 48 and 72 h (Table 1) , for continuity between the three sets of models. Tables 2 -4 show odds ratios for parasite density associated with IL-10 level at time 0 h. A higher odds ratio indicates a higher likelihood of greater parasite density in an IL-10 category compared with the reference.
IL-10 levels at 0 h and subsequent parasite densities
Higher concentrations of IL-10 at time 0 were associated with subsequently higher parasite densities at 24, 48 and 72 h of treatment (Tables 2-4 and Figure 1 ) independently of initial parasitaemia. Since the patients were treated with four different treatment regimes, adjustment was consistently made for this factor. Categorical and continuous log-transformed measures of initial parasitaemia were compared, in the same model, for the strongest association with parasitaemia at 24, 48 and 72 h. The continuous variable presented the finest-grain adjustment (data not shown) and was therefore used (in columns 2 and 3). In the final model (column 3), adjustments were made for several potential confounding factors: treatment, initial parasitaemia, temperature, age and sex. At 24 h (Table 2) , the association increased between each succeeding category of IL-10 and was statistically significant for the categories with the two highest IL-10 levels compared to the lowest. At 48 and 72 h, the levels went up until the second highest category of IL-10 and then reached a plateau (Tables 3 and 4 ). These associations were independent Parasite density (parasites /µL) was divided into fifths of its distribution at 24 h (24 h) and the same division was used for all time points. IL-10 and temperature values are categorized according to plasma levels (pg /mL) or degrees Celsius (°C) at time 0 h. Each age category represents 1 year of age. SP = Sulfadoxine-Pyrimethamine.
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of all the potential confounding factors, even the finergrain measure of parasite density at 0 h. IL-10 level was predictive of parasite densities in all treatment arms and there was no significant interaction of treatment strategy with IL-10 level (P > 0·05) with regard to subsequent parasitaemia after adjustment for the main effects.
The median plasma level of IL-10 decreased during the treatment period, from the level at 0 h: 503 (lower and upper quartile: (238-1479)) pg/mL to 198 (55-483) and 124 (44-238) pg/mL at 48 and 72 h, respectively. The median levels of IL-10 at 48 and 72 h were generally higher in the groups with the higher baseline levels of IL-10 ( Figure 2 ). The odds ratios estimate risk of higher parasite density and were generated using ordered polytomous logistic regression. Adjustments were made for the variables: a treatment, b treatment and continuous log parasitaemia at time 0, c treatment, continuous log parasitaemia at time 0, age, sex and temperature at time 0. 
The odds ratios estimate risk of higher parasite density and were generated using ordered polytomous logistic regression. Adjustments were made for the variables: a treatment, b treatment and continuous log parasitaemia at time 0, c treatment, continuous log parasitaemia at time 0, age, sex and temperature at time 0. 
The odds ratios estimate risk of higher parasite density and were generated using ordered polytomous logistic regression. Adjustments were made for the variables: a treatment, b treatment and continuous log parasitaemia at time 0, c treatment, continuous log parasitaemia at time 0, age, sex and temperature at time 0.
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To test the association of TNF-α with parasitaemia, the measure of TNF-α was divided into five ordinal categories, the first representing subjects with levels below the detectable threshold and the other four representing equally sized quarters of the detectable distribution. When compared by testing trends across the categories, there was no notable or statistically significant association between TNF-α concentration and parasitaemia (data not shown).
DISCUSSION
A positive association between serum IL-10 level and parasite density in symptomatic P. falciparum malaria (before start of treatment) has been described previously (13) . The consequences of the presence of IL-10 for parasite killing are however, not known. We found associations between initial IL-10 levels and parasite densities during treatment, indicating that the IL-10 levels may play a role in the clearance of parasites during treatment. Since the IL-10 level is associated with the initial parasite burden, there is a risk that an association between IL-10 and parasite clearance may only reflect the situation that those with high parasitaemia at the start had more parasites throughout the treatment. Therefore we used a statistical model where the outcome was conditional on the initial parasitaemia (15). Such adjustment even enhanced the association between IL-10 level and the risk of having higher parasite density at 24 h. This implies that IL-10 may be a better indicator of the parasiticidal efficacy during the first day of treatment than the initial parasitaemia. This was not an artefact due to a more precise measure of the distribution of IL-10 compared with initial parasitaemia in our modelling, since we used the most precise measure of the parasite distribution at day 0. By adjusting for temperature, treatment, age and sex we found that the associations were also independent of these potential confounding factors.
Figure 1
Odds ratios and 95% confidence intervals for higher parasite densities at (a) 24, (b) 48 and (c) 72 h by IL-10 levels at 0 h were generated using ordered polytomous logistic regression. Simultaneous adjustment was made for continuous log parasitaemia at 0 h, age, sex, treatment and temperature. Category boundaries for IL-10 levels are shown in Table 1 .
Figure 2
Medians of plasma IL-10 levels during treatment. The children were divided into five consecutive groups, with increasing baseline levels of IL-10. Category boundaries for IL-10 levels are shown in Table 1 .
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Contrary to our results, Luty et al. found a negative association between parasite clearance time and in vitro induction of IL-10 production in malaria antigen stimulated PBMCs from Gabonese patients with acute P. falciparum infection (16) . Their study investigated whether the donors responded with or without IL-10 production, indicating the need of P. falciparum antigen-specific cells to obtain faster clearance of parasites during treatment. In contrast, all our patients produced IL-10 and we focused on the relevance of the magnitude of production. The apparent difference in frequency of IL-10 detection is probably caused by the use of different methods.
One limitation of measuring cytokine levels in plasma or supernatants is that the bioactivity of the cytokine may be poorly correlated with the protein level. Additionally, cytokine detection after in vitro stimulation of cells in culture may reflect conditions that are not relevant to the in vivo situation. Theoretically, re-stimulation of cells already activated in vivo, may lead to in vitro apoptosis or anergy, which may underestimate the production of that cytokine in vivo. Few studies have compared serum and ex vivo induced cytokine production during infectious diseases but those generally show inconsistent results using these different techniques (9, (17) (18) (19) . Other limitations in human studies are difficulties in measuring immune reactions in tissue or immune organs, apart from the peripheral blood. However, for blood stages of malaria the peripheral blood should be a relevant immune organ for studies of systemic regulatory molecules like IL-10. Consistent with this assumption, several studies have shown strong correlation between serum levels of IL-10 and clinical manifestations (13, 20) . The levels of IL-10 detected here were within the range detected in similar studies: they were higher than some (10) and lower than others (8, 21) .
The efficacy of anti-malarial drugs on parasite clearance depends on the sensitivity of the parasite, the drug levels over time and the immune defence (22) . In our study the patients were treated with four different drug regimens with different parasite clearance rates (14) . Type of treatment did not affect our results, since IL-10 was predictive of parasite clearance in all treatment arms and there was no interaction between IL-10 level and treatment arm. Our study thus identified a general association between IL-10 level and reduced parasite clearance irrespective of treatment. This does not necessarily imply a similar negative effect on parasite clearance in untreated malaria.
The drop in IL-10 levels over the study period implies that the IL-10 production is affected by the treatment, the reduction in parasite load or other disease causing factors. The cause-effect relationship between these variables could not be identified with our model but would be interesting to address in future studies.
Since the mechanism (s) of parasite killing has not been fully described, we can only speculate how IL-10 may influence parasite clearance. IL-10 is an important immune modulating factor executing anti-inflammatory activities by inhibiting activation of antigen-presenting cells (APC), reducing their ability to induce T cell responses (23) . IL-10 inhibits APC production of cytokines and effector molecules like NO - (23) . Stimulation of T cells in the presence of IL-10 is also thought to promote induction of regulatory T cells, which become tolerant or unresponsive to the stimulating antigen (24, 25) . The inhibitory effects seen for IL-10 on parasite killing could operate at any of these levels. NO -and reactive oxygen intermediates have been proposed as possible effector molecules in malaria parasite killing (4, 26, 27) and data suggest an association between increased levels of these molecules and shorter parasite clearance time (22, 28) . High IL-10 levels might thus aggravate the disease by downregulating the production of these molecules directly or via down-regulation of pro-inflammatory cytokines. In support of this, other reports show lower levels of plasma IL-12 or NO -in combination with higher IL-10 and TNF levels in more severe forms of malaria (12, 13) . Studying ratios between pro-and anti-inflammatory cytokines for the prognostic of parasite killing might add more information of what cytokine profiles are beneficial or detrimental (29) . In this way it was identified that hyperparasitaemia in children was associated with higher ratios of IL-10 : TNF plasma levels (11). We could not study ratios between IL-10 and TNF-α here because of insufficiently sensitivity of the TNF-α detection, but this would be worth trying in future studies. Hence, we found no univeriate association between TNF-α and parasitaemia, nor between TNF-α and any of the parasite categories.
The parasite might 'deliberately' enhance the IL-10 production in order to interfere with the balance between proand anti-inflammatory immune reactions to escape effective parasite killing. There is in vitro evidence that falciparuminfected erythrocytes increase the secretion of IL-10 and reduce the secretion of IL-12 during maturation of dendritic cells (30, 31) . These effects on DC were similar to what was found when the cells were exposed to apoptotic cells or ligation of CD36 and/or CD51. Such mechanisms might be overcome after repeated infections, since neither high levels of IL-10 nor particular pro-inflammatory responses are found in children in endemic areas with significant numbers of parasites but without clinical symptoms (21) .
Differences in the magnitude of IL-10 production may reflect differences in host characteristics, including genetic differences, semi-immunity, co-infections or nutritional status and possibly differences in parasite strains. In any event, our data suggest that higher IL-10 levels are associated with poorer subsequent parasite clearance. Thus, IL-10 levels may represent a useful prognostic marker in identifying patients who are more susceptible to slower parasite clearance.
